{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:21:17Z","timestamp":1787023277005,"version":"build-2736575974"},"reference-count":59,"publisher":"Zhejiang University Press","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Zhejiang Univ. Sci. B"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1631\/jzus.b1500181","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T18:44:05Z","timestamp":1452278645000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target?","\u795e\u7ecf\u751f\u957f\u56e0\u5b50\u4e0e\u8179\u6cfb\u578b\u80a0\u6613\u6fc0\u7efc\u5408\u5f81:\u5177\u6709\u524d\u666f\u7684\u6cbb\u7597\u9776\u70b9?"],"prefix":"10.1631","volume":"17","author":[{"given":"Xiao-juan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-kun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"635","published-online":{"date-parts":[[2016,1,10]]},"reference":[{"issue":"7","key":"81_CR1","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1136\/gut.2007.138982","volume":"57","author":"A. Akbar","year":"2008","unstructured":"Akbar, A., Yiangou, Y., Facer, P., et al., 2008. Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut, 57(7):923\u2013929. http:\/\/dx.doi.org\/10.1136\/gut.2007.138982","journal-title":"Gut"},{"issue":"3","key":"81_CR2","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1053\/j.gastro.2003.11.055","volume":"126","author":"G. Barbara","year":"2004","unstructured":"Barbara, G., Stanghellini, V., de Giorgio, R., et al., 2004. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology, 126(3):693\u2013702. http:\/\/dx.doi.org\/10.1053\/j.gastro.2003.11.055","journal-title":"Gastroenterology"},{"issue":"1","key":"81_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1053\/j.gastro.2006.11.039","volume":"132","author":"G. Barbara","year":"2007","unstructured":"Barbara, G., Wang, B., Stanghellini, V., et al., 2007. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology, 132(1):26\u201337. http:\/\/dx.doi.org\/10.1053\/j.gastro.2006.11.039","journal-title":"Gastroenterology"},{"issue":"2","key":"81_CR4","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1053\/j.gastro.2004.05.019","volume":"127","author":"F. Barreau","year":"2004","unstructured":"Barreau, F., Cartier, C., Ferrier, L., et al., 2004. Nerve growth factor mediates alterations of colonic sensitivity and mucosal barrier induced by neonatal stress in rats. Gastroenterology, 127(2):524\u2013534. http:\/\/dx.doi.org\/10.1053\/j.gastro.2004.05.019","journal-title":"Gastroenterology"},{"issue":"1","key":"81_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1113\/jphysiol.2006.120907","volume":"580","author":"F. Barreau","year":"2007","unstructured":"Barreau, F., Cartier, C., Leveque, M., et al., 2007. Pathways involved in gut mucosal barrier dysfunction induced in adult rats by maternal deprivation: corticotrophinreleasing factor and nerve growth factor interplay. J. Physiol., 580(1):347\u2013356. http:\/\/dx.doi.org\/10.1113\/jphysiol.2006.120907","journal-title":"J. Physiol."},{"issue":"5","key":"81_CR6","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1136\/gut.2007.126680","volume":"57","author":"F. Barreau","year":"2008","unstructured":"Barreau, F., Salvador-Cartier, C., Houdeau, E., et al., 2008. Long-term alterations of colonic nerve-mast cell interactions induced by neonatal maternal deprivation in rats. Gut, 57(5):582\u2013590. http:\/\/dx.doi.org\/10.1136\/gut.2007.126680","journal-title":"Gut"},{"issue":"1","key":"81_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12876-014-0189-7","volume":"14","author":"S.C. Bischoff","year":"2014","unstructured":"Bischoff, S.C., Barbara, G., Buurman, W., et al., 2014. Intestinal permeability\u2014a new target for disease prevention and therapy. BMC Gastroenterol., 14(1):189. http:\/\/dx.doi.org\/10.1186\/s12876-014-0189-7","journal-title":"BMC Gastroenterol."},{"issue":"2","key":"81_CR8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1113\/jphysiol.2003.039990","volume":"551","author":"J.K. Bonnington","year":"2003","unstructured":"Bonnington, J.K., McNaughton, P.A., 2003. Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor. J. Physiol., 551(2):433\u2013446. http:\/\/dx.doi.org\/10.1113\/jphysiol.2003.039990","journal-title":"J. Physiol."},{"key":"81_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-642-45106-5_1","volume-title":"Neurotrophic Factors","author":"M. Bothwell","year":"2014","unstructured":"Bothwell, M., 2014. NGF, BDNF, NT3, and NT4. In: Lewin, G.R., Carter, B.D. (Eds.), Neurotrophic Factors. Springer Berlin Heidelberg, p.3\u201315. http:\/\/dx.doi.org\/10.1007\/978-3-642-45106-5_1"},{"issue":"6","key":"81_CR10","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1111\/pme.12677","volume":"16","author":"C. Bramson","year":"2015","unstructured":"Bramson, C., Herrmann, D.N., Carey, W., et al., 2015. Exploring the role of tanezumab as a novel treatment for the relief of neuropathic pain. Pain Med., 16(6):1163\u20131176. http:\/\/dx.doi.org\/10.1111\/pme.12677","journal-title":"Pain Med."},{"issue":"17","key":"81_CR11","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1056\/NEJMra1207068","volume":"367","author":"M. Camilleri","year":"2012","unstructured":"Camilleri, M., 2012. Peripheral mechanisms in irritable bowel syndrome. N. Engl. J. Med., 367(17):1626\u20131635. http:\/\/dx.doi.org\/10.1056\/NEJMra1207068","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"81_CR12","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1172\/JCI29255","volume":"117","author":"N. Cenac","year":"2007","unstructured":"Cenac, N., Andrews, C.N., Holzhausen, M., et al., 2007. Role for protease activity in visceral pain in irritable bowel syndrome. J Clin. Invest., 117(3):636\u2013647. http:\/\/dx.doi.org\/10.1172\/JCI29255","journal-title":"J Clin. Invest."},{"issue":"2","key":"81_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1365-2982.2008.01171.x","volume":"21","author":"L. Chang","year":"2009","unstructured":"Chang, L., Sundaresh, S., Elliott, J., et al., 2009. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol. Motil., 21(2):149\u2013159. http:\/\/dx.doi.org\/10.1111\/j.1365-2982.2008.01171.x","journal-title":"Neurogastroenterol. Motil."},{"issue":"1","key":"81_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gtc.2010.12.006","volume":"40","author":"R.K. Choung","year":"2011","unstructured":"Choung, R.K., Locke, G.R., 2011. Epidemiology of IBS. Gastroenterol. Clin. N. Am., 40(1):1\u201310. http:\/\/dx.doi.org\/10.1016\/j.gtc.2010.12.006","journal-title":"Gastroenterol. Clin. N. Am."},{"issue":"5","key":"81_CR15","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/ajg.2009.700","volume":"105","author":"M. Co\u00ebffier","year":"2010","unstructured":"Co\u00ebffier, M., Gloro, R., Boukhettala, N., et al., 2010. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome. Am. J. Gastroenterol., 105(5):1181\u20131188. http:\/\/dx.doi.org\/10.1038\/ajg.2009.700","journal-title":"Am. J. Gastroenterol."},{"issue":"7","key":"81_CR16","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1111\/bph.12958","volume":"172","author":"A. Coelho","year":"2015","unstructured":"Coelho, A., Wolf-Johnston, A.S., Shinde, S., et al., 2015. Urinary bladder inflammation induces changes in urothelial nerve growth factor and vanilloid receptor 1. Br. J. Pharmacol., 172(7):1691\u20131699. http:\/\/dx.doi.org\/10.1111\/bph.12958","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"81_CR17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0304-3959(03)00266-5","volume":"105","author":"L. Delafoy","year":"2003","unstructured":"Delafoy, L., Raymond, F., Doherty, A.M., et al., 2003. Role of nerve growth factor in the trinitrobenzene sulfonic acidinduced colonic hypersensitivity. Pain, 105(3):489\u2013497. http:\/\/dx.doi.org\/10.1016\/S0304-3959(03)00266-5","journal-title":"Pain"},{"issue":"7","key":"81_CR18","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1136\/gut.2005.064063","volume":"55","author":"L. Delafoy","year":"2006","unstructured":"Delafoy, L., Gelot, A., Ardid, D., et al., 2006. Interactive involvement of brain derived neurotrophic factor, nerve growth factor, and calcitonin gene related peptide in colonic hypersensitivity in the rat. Gut, 55(7):940\u2013945. http:\/\/dx.doi.org\/10.1136\/gut.2005.064063","journal-title":"Gut"},{"issue":"5","key":"81_CR19","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1136\/gut.46.5.670","volume":"46","author":"F.F. Mola di","year":"2000","unstructured":"di Mola, F.F., Friess, H., Zhu, Z.W., et al., 2000. Nerve growth factor and Trk high affinity receptor (TrkA) gene expression in inflammatory bowel disease. Gut, 46(5):670\u2013678. http:\/\/dx.doi.org\/10.1136\/gut.46.5.670","journal-title":"Gut"},{"issue":"5","key":"81_CR20","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1053\/j.gastro.2015.01.042","volume":"148","author":"G. Dothel","year":"2015","unstructured":"Dothel, G., Barbaro, M.R., Boudin, H., et al., 2015. Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology, 148(5):1002\u20131011. http:\/\/dx.doi.org\/10.1053\/j.gastro.2015.01.042","journal-title":"Gastroenterology"},{"issue":"5","key":"81_CR21","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1016\/j.juro.2010.12.088","volume":"185","author":"R.J. Evans","year":"2011","unstructured":"Evans, R.J., Moldwin, R.M., Cossons, N., et al., 2011. Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis. J. Urol., 185(5):1716\u20131721. http:\/\/dx.doi.org\/10.1016\/j.juro.2010.12.088","journal-title":"J. Urol."},{"issue":"3","key":"81_CR22","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0016-5085(03)01057-6","volume":"125","author":"L. Ferrier","year":"2003","unstructured":"Ferrier, L., Mazelin, L., Cenac, N., et al., 2003. Stress-induced disruption of colonic epithelial barrier: role of interferon and myosin light chain kinase in mice. Gastroenterology, 125(3):795\u2013804. http:\/\/dx.doi.org\/10.1016\/S0016-5085(03)01057-6","journal-title":"Gastroenterology"},{"issue":"9","key":"81_CR23","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.pain.2014.06.004","volume":"155","author":"J.S. Gimbel","year":"2014","unstructured":"Gimbel, J.S., Kivitz, A.J., Bramson, C., et al., 2014. Long-term safety and effectiveness of tanezumab as treatment for chronic low back pain. Pain, 155(9):1793\u20131801. http:\/\/dx.doi.org\/10.1016\/j.pain.2014.06.004","journal-title":"Pain"},{"issue":"11","key":"81_CR24","first-page":"861","volume":"30","author":"J.X. Hao","year":"2010","unstructured":"Hao, J.X., Duan, L.P., 2010. Progress in the relationship of intestinal mucosal barrier function and irritable bowel syndrome. Chin. J. Dig., 30(11):861\u2013863 (in Chinese). http:\/\/dx.doi.org\/10.3760\/cma.j.issn.0254-1432.2010.11.026","journal-title":"Chin. J. Dig."},{"issue":"7","key":"81_CR25","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/j.1365-2982.2010.01498.x","volume":"22","author":"A.V. Keita","year":"2010","unstructured":"Keita, A.V., S\u00f6derholm, J.D., 2010. The intestinal barrier and its regulation by neuroimmune factors. Neurogastroenterol. Motil., 22(7):718\u2013733. http:\/\/dx.doi.org\/10.1111\/j.1365-2982.2010.01498.x","journal-title":"Neurogastroenterol. Motil."},{"issue":"14","key":"81_CR26","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1017\/S003329171400052X","volume":"44","author":"P.J. Kennedy","year":"2014","unstructured":"Kennedy, P.J., Cryan, J.F., Quigley, E.M., et al., 2014. A sustained hypothalamic-pituitary-adrenal axis response to acute psychosocial stress in irritable bowel syndrome. Psychol. Med., 44(14):3123\u20133134. http:\/\/dx.doi.org\/10.1017\/S003329171400052X","journal-title":"Psychol. Med."},{"issue":"2","key":"81_CR27","doi-asserted-by":"publisher","first-page":"244","DOI":"10.5056\/jnm.2013.19.2.244","volume":"19","author":"H. Lee","year":"2013","unstructured":"Lee, H., Park, J.H., Park, D.I., et al., 2013. Mucosal mast cell count is associated with intestinal permeability in patients with diarrhea predominant irritable bowel syndrome. J. Neurogastroenterol. Motil., 19(2):244\u2013250. http:\/\/dx.doi.org\/10.5056\/jnm.2013.19.2.244","journal-title":"J. Neurogastroenterol. Motil."},{"issue":"9","key":"81_CR28","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1073\/pnas.91.9.3739","volume":"91","author":"A. Leon","year":"1994","unstructured":"Leon, A., Buriani, A., Dal Toso, R., et al., 1994. Mast cells synthesize, store, and release nerve growth factor. PNAS, 91(9):3739\u20133743. http:\/\/dx.doi.org\/10.1073\/pnas.91.9.3739","journal-title":"PNAS"},{"issue":"11","key":"81_CR29","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0166-2236(96)10058-8","volume":"19","author":"R. Levi-Montalcini","year":"1996","unstructured":"Levi-Montalcini, R., Skaper, S.D., Dal Toso, R., et al., 1996. Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci., 19(11):514\u2013520. http:\/\/dx.doi.org\/10.1016\/S0166-2236(96)10058-8","journal-title":"Trends Neurosci."},{"key":"81_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/978-3-642-45106-5_10","volume-title":"Neurotrophic Factors","author":"G.R. Lewin","year":"2014","unstructured":"Lewin, G.R., Lechner, S.G., Smith, E.S., 2014. Nerve growth factor and nociception: from experimental embryology to new analgesic therapy. In: Lewin, G.R., Carter, B.D. (Eds.), Neurotrophic Factors. Springer Berlin Heidelberg, p.251\u2013282. http:\/\/dx.doi.org\/10.1007\/978-3-642-45106-5_10"},{"issue":"10","key":"81_CR31","first-page":"593","volume":"19","author":"Q. Li","year":"2014","unstructured":"Li, Q., Xu, C.P., Yang, M., et al., 2014. Expression and significance of nerve growth factor in ulcerative colitis. Chin. J. Gastroenterol., 19(10):593\u2013595 (in Chinese). http:\/\/dx.doi.org\/10.3969\/j.issn.1008-7125.2014.10.004","journal-title":"Chin. J. Gastroenterol."},{"issue":"10","key":"81_CR32","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1631\/jzus.B1400143","volume":"15","author":"L. Liu","year":"2014","unstructured":"Liu, L., Liu, B.N., Chen, S., et al., 2014. Visceral and somatic hypersensitivity, autonomic cardiovascular dysfunction and low-grade inflammation in a subset of irritable bowel syndrome patients. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 15(10):907\u2013914. http:\/\/dx.doi.org\/10.1631\/jzus.B1400143","journal-title":"J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.)"},{"issue":"8","key":"81_CR33","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1136\/gutjnl-2012-302093","volume":"62","author":"C. Mart\u00ednez","year":"2013","unstructured":"Mart\u00ednez, C., Lobo, B., Pigrau, M., et al., 2013. Diarrhoeapredominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. Gut, 62(8):1160\u20131168. http:\/\/dx.doi.org\/10.1136\/gutjnl-2012-302093","journal-title":"Gut"},{"issue":"6","key":"81_CR34","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1136\/gut.47.6.861","volume":"47","author":"E.A. Mayer","year":"2000","unstructured":"Mayer, E.A., 2000. The neurobiology of stress and gastrointestinal disease. Gut, 47(6):861\u2013869. http:\/\/dx.doi.org\/10.1136\/gut.47.6.861","journal-title":"Gut"},{"issue":"3","key":"81_CR35","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/apt.12829","volume":"40","author":"Z. Mujagic","year":"2014","unstructured":"Mujagic, Z., Ludidi, S., Keszthelyi, D., et al., 2014. Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to confounders. Aliment. Pharmacol. Ther., 40(3):288\u2013397. http:\/\/dx.doi.org\/10.1111\/apt.12829","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"81_CR36","doi-asserted-by":"publisher","first-page":"G1028","DOI":"10.1152\/ajpgi.00066.2003","volume":"285","author":"M. Neunlist","year":"2003","unstructured":"Neunlist, M., Toumi, F., Oreschkova, T., et al., 2003. Human ENS regulates the intestinal epithelial barrier permeability and a tight junction-associated protein ZO-1 via VIPergic pathways. Am. J. Physiol. Gastrointest. Liver Physiol., 285(5):G1028\u2013G1036. http:\/\/dx.doi.org\/10.1152\/ajpgi.00066.2003","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"5","key":"81_CR37","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.urology.2012.07.035","volume":"80","author":"J.C. Nickel","year":"2012","unstructured":"Nickel, J.C., Atkinson, G., Krieger, J.N., et al., 2012. Preliminary assessment of safety and efficacy in proof-ofconcept, randomized clinical trial of tanezumab for chronic prostatitis\/chronic pelvic pain syndrome. Urology, 80(5):1105\u20131110. http:\/\/dx.doi.org\/10.1016\/j.urology.2012.07.035","journal-title":"Urology"},{"issue":"7\u20138","key":"81_CR38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.lfs.2007.11.027","volume":"82","author":"K. Ohashi","year":"2008","unstructured":"Ohashi, K., Sato, Y., Kawai, M., et al., 2008. Abolishment of TNBS-induced visceral hypersensitivity in mast cell deficient rats. Life Sci., 82(7\u20138):419\u2013423. http:\/\/dx.doi.org\/10.1016\/j.lfs.2007.11.027","journal-title":"Life Sci."},{"issue":"6","key":"81_CR39","doi-asserted-by":"publisher","first-page":"e39935","DOI":"10.1371\/journal.pone.0039935","volume":"7","author":"E.L. Overman","year":"2012","unstructured":"Overman, E.L., Rivier, J.E., Moeser, A.J., 2012. CRF induces intestinal epithelial barrier injury via the release of mast cell proteases and TNF-a. PLoS ONE, 7(6):e39935. http:\/\/dx.doi.org\/10.1371\/journal.pone.0039935","journal-title":"PLoS ONE"},{"issue":"2","key":"81_CR40","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3346\/jkms.2003.18.2.204","volume":"18","author":"C.H. Park","year":"2003","unstructured":"Park, C.H., Joo, Y.E., Choi, S.K., 2003. Activated mast cell infiltrate in close proximity to enteric nerves in diarrheapredominant irritable bowel syndrome. J. Korean Med. Sci., 18(2):204\u2013210. http:\/\/dx.doi.org\/10.3346\/jkms.2003.18.2.204","journal-title":"J. Korean Med. Sci."},{"issue":"2","key":"81_CR41","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/gut.2007.140806","volume":"58","author":"T. Piche","year":"2009","unstructured":"Piche, T., Barbara, G., Aubert, P., et al., 2009. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut, 58(2):196\u2013201. http:\/\/dx.doi.org\/10.1136\/gut.2007.140806","journal-title":"Gut"},{"issue":"3","key":"81_CR42","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.pain.2009.11.022","volume":"148","author":"R. Rukwied","year":"2010","unstructured":"Rukwied, R., Mayer, A., Kluschina, O., et al., 2010. NGF induces non-inflammatory localized and lasting mechanical and thermal hypersensitivity inhuman skin. Pain, 148(3):407\u2013413. http:\/\/dx.doi.org\/10.1016\/j.pain.2009.11.022","journal-title":"Pain"},{"issue":"10","key":"81_CR43","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1016\/j.pain.2013.05.051","volume":"154","author":"P. Sanga","year":"2013","unstructured":"Sanga, P., Katz, N., Polverejan, E., et al., 2013. Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in the treatment of patients with moderate to severe osteoarthritis pain. Pain, 154(10):1910\u20131919. http:\/\/dx.doi.org\/10.1016\/j.pain.2013.05.051","journal-title":"Pain"},{"issue":"10","key":"81_CR44","first-page":"663","volume":"31","author":"F. Shen","year":"2011","unstructured":"Shen, F., Li, D.G., Zhou, H.Q., 2011. An epidemiological investigation of irritable bowel syndrome in Shanghai Songjiang communities. Chin. J. Dig., 31(10):663\u2013668 (in Chinese). http:\/\/dx.doi.org\/10.3760\/cma.j.issn.0254-1432.2011.10.005","journal-title":"Chin. J. Dig."},{"issue":"11","key":"81_CR45","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s00535-013-0919-6","volume":"49","author":"R.J. Shulman","year":"2014","unstructured":"Shulman, R.J., Jarrett, M.E., Cain, K.C., et al., 2014. Associations among gut permeability, inflammatory markers, and symptoms in patients with irritable bowel syndrome. J. Gastroenterol., 49(11):1467\u20131476. http:\/\/dx.doi.org\/10.1007\/s00535-013-0919-6","journal-title":"J. Gastroenterol."},{"issue":"2","key":"81_CR46","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0169-328X(01)00314-X","volume":"97","author":"S.D. Skaper","year":"2001","unstructured":"Skaper, S.D., Pollock, M., Facci, L., 2001. Mast cells differentially express and release active high molecular weight neurotrophins. Mol. Brain Res., 97(2):177\u2013185. http:\/\/dx.doi.org\/10.1016\/S0169-328X(01)00314-X","journal-title":"Mol. Brain Res."},{"issue":"4","key":"81_CR47","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0896-6273(00)81003-X","volume":"20","author":"W.D. Snider","year":"1998","unstructured":"Snider, W.D., McMahon, S.B., 1998. Tackling pain at the source: new ideas about nociceptors. Neuron, 20(4):629\u2013632. http:\/\/dx.doi.org\/10.1016\/S0896-6273(00)81003-X","journal-title":"Neuron"},{"issue":"5","key":"81_CR48","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1085\/jgp.200609576","volume":"128","author":"A.T. Stein","year":"2006","unstructured":"Stein, A.T., Ufret-Vincenty, C.A., Hua, L., et al., 2006. Phosphoinositide 3-kinase binds to TRPV1 and mediates NGF-stimulated TRPV1 trafficking to the plasma membrane. J. Gen. Physiol., 128(5):509\u2013522. http:\/\/dx.doi.org\/10.1085\/jgp.200609576","journal-title":"J. Gen. Physiol."},{"issue":"7","key":"81_CR49","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.pain.2014.03.018","volume":"155","author":"P.J. Tiseo","year":"2014","unstructured":"Tiseo, P.J., Kivitz, A.J., Ervin, J.E., et al., 2014. Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: results from a double-blind, placebocontrolled exploratory study in osteoarthritis of the knee. Pain, 155(7):1245\u20131252. http:\/\/dx.doi.org\/10.1016\/j.pain.2014.03.018","journal-title":"Pain"},{"issue":"10","key":"81_CR50","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1111\/j.1365-2982.2009.01339.x","volume":"21","author":"R.M. Wijngaard van den","year":"2009","unstructured":"van den Wijngaard, R.M., Klooker, T.K., Welting, O., et al., 2009. Essential role for TRPV1 in stress-induced (mast cell-dependent) colonic hypersensitivity in maternally separated rats. Neurogastroenterol. Motil., 21(10):1107-e94. http:\/\/dx.doi.org\/10.1111\/j.1365-2982.2009.01339.x","journal-title":"Neurogastroenterol. Motil."},{"issue":"3","key":"81_CR51","first-page":"285","volume":"19","author":"W.L. Wang","year":"2010","unstructured":"Wang, W.L., Wu, W.C., 2010. Nerve growth factor and irritable bowel syndrome. Chin. J. Gastroenterol. Hepatol., 19(3):285\u2013287 (in Chinese). http:\/\/dx.doi.org\/10.3969\/j.issn.1006-5709.2010.03.029","journal-title":"Chin. J. Gastroenterol. Hepatol."},{"issue":"8","key":"81_CR52","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1365-2982.2012.01933.x","volume":"24","author":"S. Willot","year":"2012","unstructured":"Willot, S., Gauthier, C., Patey, N., et al., 2012. Nerve growth factor content is increased in the rectal mucosa of children with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol. Motil., 24(8):734-e347. http:\/\/dx.doi.org\/10.1111\/j.1365-2982.2012.01933.x","journal-title":"Neurogastroenterol. Motil."},{"issue":"5","key":"81_CR53","doi-asserted-by":"publisher","first-page":"563","DOI":"10.11569\/wcjd.v16.i5.563","volume":"16","author":"X. Yao","year":"2008","unstructured":"Yao, X., Yang, Y.S., Zhao, K.B., et al., 2008. Clinical features and subtypes of irritable bowel syndrome based on Rome III diagnostic criteria. World Chin. J. Digestol., 16(5):563\u2013566 (in Chinese). http:\/\/dx.doi.org\/10.3969\/j.issn.1009-3079.2008.05.023","journal-title":"World Chin. J. Digestol."},{"issue":"11","key":"81_CR54","first-page":"764","volume":"28","author":"Y. Yu","year":"2008","unstructured":"Yu, Y., Gao, J., Zhang, W., et al., 2008. Effect of nerve growth factor on colorectal visceral hypersensitivity in rats. Chin. J. Dig., 28(11):764\u2013766 (in Chinese). http:\/\/dx.doi.org\/10.3760\/j.issn:0254-1432.2008.11.011","journal-title":"Chin. J. Dig."},{"issue":"12","key":"81_CR55","first-page":"969","volume":"53","author":"L. Zhang","year":"2014","unstructured":"Zhang, L., Duan, L.P., Liu, Y.X., et al., 2014. A meta-analysis of the prevalence and risk factors of irritable bowel syndrome in Chinese community. Chin. J. Intern. Med., 53(12):969\u2013975 (in Chinese). http:\/\/dx.doi.org\/10.3760\/cma.j.issn.0578-1426.2014.12.011","journal-title":"Chin. J. Intern. Med."},{"issue":"1\u20132","key":"81_CR56","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.pain.2009.06.017","volume":"146","author":"Q.Q. Zhou","year":"2009","unstructured":"Zhou, Q.Q., Zhang, B.Y., Verne, G.N., 2009. Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome. Pain, 146(1\u20132):41\u201346. http:\/\/dx.doi.org\/10.1016\/j.pain.2009.06.017","journal-title":"Pain"},{"issue":"2","key":"81_CR57","first-page":"117","volume":"19","author":"X.P. Zhou","year":"2014","unstructured":"Zhou, X.P., Li, X.L., 2014. Advances in studies on visceral hypersensitivity of irritable bowel syndrome. Chin. J. Gastroenterol., 19(2):117\u2013119 (in Chinese). http:\/\/dx.doi.org\/10.3969\/j.issn.1008-7125.2014.02.011","journal-title":"Chin. J. Gastroenterol."},{"issue":"4","key":"81_CR58","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.mcn.2007.01.005","volume":"34","author":"W. Zhu","year":"2007","unstructured":"Zhu, W., Oxford, G.S., 2007. Phosphoinositide-3-kinase and mitogen activated protein kinase signaling pathways mediate acute NGF sensitization of TRPV1. Mol. Cell. Neurosci., 34(4):689\u2013700. http:\/\/dx.doi.org\/10.1016\/j.mcn.2007.01.005","journal-title":"Mol. Cell. Neurosci."},{"issue":"38","key":"81_CR59","doi-asserted-by":"publisher","first-page":"8300","DOI":"10.1523\/JNEUROSCI.2893-04.2004","volume":"24","author":"Z.Y. Zhuang","year":"2004","unstructured":"Zhuang, Z.Y., Xu, H., Clapham, D.E., et al., 2004. Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization. J. Neurosci., 24(38):8300\u20138309. http:\/\/dx.doi.org\/10.1523\/JNEUROSCI.2893-04.2004","journal-title":"J. Neurosci."}],"container-title":["Journal of Zhejiang University-SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B1500181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1631\/jzus.B1500181\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B1500181","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B1500181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T01:00:16Z","timestamp":1559610016000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1631\/jzus.B1500181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["81"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b1500181","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"value":"1673-1581","type":"print"},{"value":"1862-1783","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}